Knockdown of sarcolipin (SLN) impairs substrate utilization in human skeletal muscle cells.

Abel M Mengeste, Parmeshwar Katare, Andrea Dalmao Fernandez, Jenny Lund, Hege G Bakke, David Baker, Stefano Bartesaghi, Xiao-Rong Peng, Arild C Rustan, G Hege Thoresen, Eili Tranheim Kase

Molecular biology reports 2022 Jul

filter terms:

Recent studies have highlighted that uncoupling of sarco-/endoplasmic reticulum Ca2+-ATPase (SERCA) by sarcolipin (SLN) increases ATP consumption and contributes to heat liberation. Exploiting this thermogenic mechanism in skeletal muscle may provide an attractive strategy to counteract obesity and associated metabolic disorders. In the present study, we have investigated the role of SLN on substrate metabolism in human skeletal muscle cells. After generation of skeletal muscle cells with stable SLN knockdown (SLN-KD), cell viability, glucose and oleic acid (OA) metabolism, mitochondrial function, as well as gene expressions were determined. Depletion of SLN did not influence cell viability. However, glucose and OA oxidation were diminished in SLN-KD cells compared to control myotubes. Basal respiration measured by respirometry was also observed to be reduced in cells with SLN-KD. The metabolic perturbation in SLN-KD cells was reflected by reduced gene expression levels of peroxisome proliferator-activated receptor γ coactivator 1α (PGC1α) and forkhead box O1 (FOXO1). Furthermore, accumulation of OA was increased in cells with SLN-KD compared to control cells. These effects were accompanied by increased lipid formation and incorporation of OA into complex lipids. Additionally, formation of complex lipids and free fatty acid from de novo lipogenesis with acetate as substrate was enhanced in SLN-KD cells. Detection of lipid droplets using Oil red O staining also showed increased lipid accumulation in SLN-KD cells. Overall, our study sheds light on the importance of SLN in maintaining metabolic homeostasis in human skeletal muscle. Findings from the current study suggest that therapeutic strategies involving SLN-mediated futile cycling of SERCA might have significant implications in the treatment of obesity and associated metabolic disorders. © 2022. The Author(s).

Citation

Abel M Mengeste, Parmeshwar Katare, Andrea Dalmao Fernandez, Jenny Lund, Hege G Bakke, David Baker, Stefano Bartesaghi, Xiao-Rong Peng, Arild C Rustan, G Hege Thoresen, Eili Tranheim Kase. Knockdown of sarcolipin (SLN) impairs substrate utilization in human skeletal muscle cells. Molecular biology reports. 2022 Jul;49(7):6005-6017